Bonky 0.25mcg Capsule

Bonky 0.25mcg Capsule contains alfacalcidol 0.25 micrograms as its active ingredient. Alfacalcidol is a synthetic analogue of active vitamin D (1-alpha-hydroxycholecalciferol) that is converted in the liver to calcitriol, the biologically active form of vitamin D. It is supplied as an oral capsule.

Alfacalcidol-containing products, including well-known international brands such as One-Alpha, are classified as prescription medicines in most reference markets, including the United Kingdom, and are used only under medical supervision because of their potency and the risk of hypercalcaemia with inappropriate dosing. This distinguishes alfacalcidol from ordinary cholecalciferol (vitamin D3) supplements, which are generally available over the counter; alfacalcidol requires individualised dosing and monitoring of blood calcium levels by a doctor. Based on the evidence gathered for this review, Bonky 0.25mcg Capsule should be treated as requiring a doctor’s prescription and pharmacist oversight in Malaysia, consistent with how alfacalcidol products are classified internationally and with DoctorOnCall’s own published information stating that alfacalcidol requires a valid prescription in Malaysia; the exact NPRA registration and scheduling status specifically for the “Bonky” brand could not be independently confirmed through the regulatory portal during this review, and should be verified by a pharmacist before this product is listed for unrestricted self-selection.

Bonky is supplied as a capsule for oral use. Pack size and exact formulation details should be confirmed against the product packaging or a pharmacist, as should the appropriateness of any self-directed purchase, given the prescription-controlled nature of alfacalcidol in comparable markets.

Take Bonky exactly as directed by the prescribing doctor, swallowing the capsule whole with water; do not adjust the dose or frequency without medical advice, and do not share this medicine with anyone else.

Alfacalcidol dosing is individualised by a doctor based on the patient’s condition, blood calcium and phosphate levels, and response to treatment, and must not be self-adjusted. Because of the risk of hypercalcaemia with excess dosing, this product should only be taken exactly as prescribed by a doctor, with regular monitoring of blood calcium levels as advised by the prescribing doctor. Do not take a double dose to make up for a missed dose; consult a doctor or pharmacist for guidance on a missed dose. Seek medical attention promptly if symptoms of high blood calcium occur, such as persistent nausea, vomiting, constipation, excessive thirst, or confusion.

Use before the expiry date printed on the packaging.

Store below 30°C in a cool, dry place away from direct sunlight, and keep out of reach of children.

• Known hypersensitivity to alfacalcidol or any capsule component.
• Hypercalcaemia or conditions associated with vitamin D toxicity.
• Should not be used without a doctor’s prescription and ongoing medical supervision.
• Not to be used for self-directed treatment of suspected vitamin D deficiency without medical assessment, given the difference in potency compared with standard vitamin D3 supplements.

• Concurrent use with calcium supplements or other vitamin D-containing products may increase the risk of hypercalcaemia and should only be combined under a doctor’s supervision.
• Thiazide diuretics may increase the risk of elevated blood calcium levels when taken with alfacalcidol.
• Certain anticonvulsant medicines may reduce the effectiveness of alfacalcidol; inform the doctor of all other medicines being taken.
• Digoxin and related heart medicines carry an increased risk of toxicity if hypercalcaemia develops during alfacalcidol treatment.

• Take Bonky only as prescribed by a doctor; do not self-adjust the dose.
• Keep scheduled blood tests for calcium monitoring as advised by the prescribing doctor.
• Inform any other doctor or pharmacist that you are taking alfacalcidol before starting new medicines or supplements.
• Store the capsules away from direct sunlight and moisture.
• Keep out of reach of children.
• Do not stop or restart this medicine without consulting the prescribing doctor.

Precautions: Alfacalcidol should only be used under the supervision of a doctor, with periodic monitoring of blood calcium and kidney function. It should be used with particular caution in individuals with kidney disease, and in pregnancy or breastfeeding only if a doctor determines the benefit outweighs the risk. This product should not be purchased or used as a general self-care vitamin D supplement without a doctor’s assessment.

When to See a Doctor or Pharmacist: Speak to a doctor before starting, stopping, or adjusting the dose of this medicine, and seek prompt medical attention if symptoms of high blood calcium develop. Anyone unsure whether this product is appropriate for them, or who does not have a current prescription, should consult a doctor or pharmacist before use.